Global Cluster Headaches Market – Industry Trends & Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Jul 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cluster Headaches Market By Drug Type (Triptans, Octreotide, Opioids, Others), Drug Application (Abortive, Transitional, Preventative), Product Types (Calcium Channel Blockers, Corticosteroids, Sumatriptan, Lithium Carbonate, Ergots, Melatonin, Anti-seizure, Local Anesthetics), End- User (Hospitals Clinics, Private Clinics, Retail Pharmacies and Drug Stores, E-commerce), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Cluster Headaches Market

Global cluster headaches market is set to witness a steady CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing healthcare awareness and rising demand for diagnosis of cluster headache is the factor for the growth of this market.

Market Definition: Global Cluster Headaches Market

Cluster headaches are a kind of a headache which usually occurs in a series of pattern. They are very painful and happen several times in a day. Usually the area around the eyes and one side of the head is affected by these headaches. These headaches often happen suddenly and can last for months and even for years. Calcium channel blocker, sumatriptan, lithium carbonate, melatonin, local anesthetics and others are some of the common product types of the cluster headaches. Drugs such as triptans and octreotide are used for the treatment so that they can decrease the occurrence of the headache and reduce their period.

Market Drivers

  • Rising aging population will drive the market growth
  • Technological advancement and development in healthcare industry will propel  the growth of the market
  • Growing television viewing and computer usage among population is also driving the market growth
  • Increasing willingness among population to spend more on healthcare treatment will also drive the market growth

Market Restraints

  • Lack of proper knowledge among healthcare provider will restrain the market growth
  • Unfavorable health care policies will also hamper the market growth
  • Increasing measure by government to lessen healthcare expenditure will also restrict the growth for this market

Segmentation: Global Cluster Headaches Market

By Drug Type

  • Triptans
  • Octreotide
  • Opioids
  • Others

By Drug Application

  • Abortive
  • Transitional
  • Preventative

By Product Types

  • Calcium Channel Blockers
  • Corticosteroids
  • Sumatriptan
  • Lithium Carbonate
  • Ergots
  • Melatonin
  • Anti-seizure
  • Local Anesthetics

By End- User

  • Hospitals Clinics
  • Private Clinics
  • Retail Pharmacies and Drug Stores
  • E-commerce

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In June 2019, U.S. Food and Drug Administration announced that they have approved a new injection Emgality (galcanezumab-gnlm) solution which is specially designed for the adults with episodic cluster headache. The main aim of the approval is to meet the unmet needs of the patient and provide them solution which can decrease the frequency of the episodic cluster headache.
  • In March 2019, Eli Lilly and Company announced that they have been granted by FDA for Priority Review for its supplemental Biologics License Application (sBLA) for Emgality injection. This injection is specially designed to provide treatment to adults’ for episodic cluster headache. The main aim of the launch is to provide better treatment to the patients with cluster headaches.

Competitive Analysis:

Global cluster headaches market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cluster headaches market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global cluster headaches market are Center Ventures, Eli Lilly and Company, Novartis AG, Teva Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Par Pharmaceutical, WOCKHARDT, Fresenius Kabi USA, Sagent Pharmaceuticals, Inc., Chengdu Tiantaishan pharmaceutical Co.,Ltd, WINSTON PHARMACEUTICALS, Inc., Autonomic Technologies, Inc., GlaxoSmithKline plc, Aurobindo Pharma., Shanghai Soho Yiming Pharmaceutical Co., Ltd., Sihuan Pharmaceutical Holdings Group Ltd., and others.

Research Methodology: Global Cluster Headaches Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global cluster headaches market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART